Total Payments
$32,544
2024 Payments
$1,416
Companies
51
Transactions
915
Medicare Patients
4,329
Medicare Billing
$566,080
Payment Breakdown by Category
Food & Beverage$20,575 (63.2%)
Travel$11,281 (34.7%)
Education$672.72 (2.1%)
Other$16.04 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,575 | 876 | 63.2% |
| Travel and Lodging | $11,281 | 16 | 34.7% |
| Education | $672.72 | 22 | 2.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16.04 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $10,852 | 47 | $0 (2020) |
| Amgen Inc. | $1,961 | 85 | $0 (2024) |
| Boston Scientific Corporation | $1,743 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,731 | 80 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,507 | 85 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,397 | 71 | $0 (2024) |
| Cardiovascular Systems Inc. | $1,168 | 8 | $0 (2022) |
| Esperion Therapeutics, Inc. | $1,156 | 36 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,115 | 49 | $0 (2024) |
| Abbott Laboratories | $1,076 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,416 | 61 | Kiniksa Pharmaceuticals International, plc ($162.54) |
| 2023 | $2,340 | 104 | E.R. Squibb & Sons, L.L.C. ($305.05) |
| 2022 | $2,612 | 110 | Novo Nordisk Inc ($333.16) |
| 2021 | $2,615 | 121 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($227.06) |
| 2020 | $3,476 | 116 | Medtronic Vascular, Inc. ($1,061) |
| 2019 | $4,474 | 109 | Boston Scientific Corporation ($1,558) |
| 2018 | $11,604 | 143 | Medtronic Vascular, Inc. ($8,544) |
| 2017 | $4,007 | 151 | Cardiovascular Systems Inc. ($1,154) |
All Payment Transactions
915 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiology | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $44.55 | General |
| Category: Medical Device | ||||||
| 11/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: Not Applicable | ||||||
| 11/20/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: Not Applicable | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $107.42 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/06/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $36.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Cardiology | ||||||
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Not Applicable | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Not Applicable | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiology | ||||||
| 07/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,007 | 1,437 | $424,710 | $137,723 |
| 2022 | 25 | 1,059 | 1,962 | $466,329 | $140,612 |
| 2021 | 26 | 1,189 | 2,235 | $521,429 | $161,376 |
| 2020 | 25 | 1,074 | 2,083 | $438,731 | $126,369 |
Total Patients
4,329
Total Services
7,717
Medicare Billing
$566,080
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 178 | 334 | $100,200 | $36,024 | 36.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 104 | 115 | $86,250 | $22,830 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 95 | $47,500 | $14,656 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 126 | $18,900 | $9,932 | 52.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 15 | 15 | $22,500 | $7,105 | 31.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 31 | 33 | $14,850 | $6,539 | 44.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 21 | 21 | $21,000 | $5,092 | 24.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $12,500 | $4,929 | 39.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 15 | 17 | $7,650 | $4,422 | 57.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 199 | 314 | $21,980 | $4,178 | 19.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 26 | 44 | $6,600 | $3,376 | 51.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 43 | $8,600 | $3,070 | 35.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 21 | $8,400 | $2,713 | 32.3% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 12 | 13 | $5,850 | $2,458 | 42.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 15 | 30 | $6,000 | $2,117 | 35.3% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 25 | 33 | $3,300 | $1,896 | 57.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 33 | $4,950 | $1,468 | 29.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 23 | 24 | $7,200 | $1,448 | 20.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 13 | $3,250 | $1,324 | 40.7% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 29 | 29 | $2,480 | $1,132 | 45.7% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 29 | 30 | $7,500 | $658.84 | 8.8% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 29 | 29 | $7,250 | $356.40 | 4.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 296 | $88,800 | $31,516 | 35.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 92 | 101 | $75,750 | $18,856 | 24.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 89 | 108 | $54,000 | $16,158 | 29.9% |
About Dr. Remo Morelli, MD
Dr. Remo Morelli, MD is a Cardiovascular Disease healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932240595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Remo Morelli, MD has received a total of $32,544 in payments from pharmaceutical and medical device companies, with $1,416 received in 2024. These payments were reported across 915 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($20,575).
As a Medicare-enrolled provider, Morelli has provided services to 4,329 Medicare beneficiaries, totaling 7,717 services with total Medicare billing of $566,080. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location San Francisco, CA
- Active Since 02/08/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1932240595
Products in Payments
- Resolute (Device) $8,348
- WATCHMAN (Device) $1,641
- ENTRESTO (Drug) $1,626
- XARELTO (Drug) $1,456
- Repatha (Biological) $1,293
- NEXLETOL (Drug) $1,156
- Coronary Orbital Atherectomy System (Device) $1,154
- LifeVest (Device) $1,115
- ELIQUIS (Drug) $1,009
- HawkOne (Device) $1,007
- JARDIANCE (Drug) $882.71
- Corlanor (Drug) $655.11
- PRALUENT ALIROCUMAB INJECTION (Biological) $588.63
- MULTAQ (Drug) $584.77
- Fox Sv PTA catheter and Armada 14 percutaneous catheter and Viatrac 14 Plus peripheral catheter (Device) $531.47
- PRADAXA (Drug) $509.50
- Carnation Ambulatory Monitor (Device) $454.26
- VERQUVO (Drug) $447.53
- Ozempic (Drug) $411.91
- Rybelsus (Drug) $387.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in San Francisco
Dr. Philip Sager, Md, MD
Cardiovascular Disease — Payments: $851,687
Cardiovascular Disease $851,687
Dr. Melvin Scheinman, M.d, M.D
Cardiovascular Disease — Payments: $315,387
Cardiovascular Disease $315,387
Dr. Henry Hsia, Md, MD
Cardiovascular Disease — Payments: $296,299
Cardiovascular Disease $296,299
Edward Gerstenfeld, Md, MD
Cardiovascular Disease — Payments: $198,638
Cardiovascular Disease $198,638
Dr. Lloyd Klein, Md, MD
Cardiovascular Disease — Payments: $176,194
Cardiovascular Disease $176,194
Robert Gillespie, M.d, M.D
Cardiovascular Disease — Payments: $116,323
Cardiovascular Disease $116,323